{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:52:22Z","timestamp":1785466342766,"version":"3.56.0"},"reference-count":26,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Linacre Q"],"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:p>This opinion addresses the licitness, quasi-benefits, and consequences of using aborted fetal tissue in vaccines and in medical research. The Catholic Church permits temporary use of vaccines generated using aborted fetal tissue to protect children from preventable diseases until alternative vaccines that do not use aborted fetal tissue are available. In medical research, cell lines that were generated from elective abortions should be avoided and alternative cell lines of licit origin utilized. The association between in utero Zika virus infections and microcephaly has increased the demand for fetal tissue to establish causality and to understand disease progression. These studies require extensive oversight as they could directly encourage elective abortions. The consequence of the use of fetal tissue from elective abortions is desensitization of beneficiaries to the original illicit act of abortion thereby obscuring the value of all human life and potentially leading to scandal.<\/jats:p>\n                  <jats:p>Summary: The use of fetal tissue from elective abortions is commonplace in the pharmaceutical industry and in medical research. This opinion addresses the licitness, quasi-benefits, and consequences of using fetal tissue from elective abortions in vaccines and in medical research. All people of good conscience have the responsibility to voice opposition to the use of fetal tissue from elective abortions in order to promote development of alternatives, affirm the value of all human life and limit scandal.<\/jats:p>","DOI":"10.1177\/0024363918761715","type":"journal-article","created":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T07:18:37Z","timestamp":1522221517000},"page":"13-17","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":7,"title":["Use of Aborted Fetal Tissue in Vaccines and Medical Research Obscures the Value of All Human Life"],"prefix":"10.1177","volume":"85","author":[{"given":"Kyle Christopher","family":"McKenna","sequence":"first","affiliation":[{"name":"Franciscan University of Steubenville, Steubenville, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2018,3,28]]},"reference":[{"key":"bibr1-0024363918761715","unstructured":"American Academy of Pediatrics. 2016. \u201cImmunization Schedules for 2016.\u201d http:\/\/redbook.solutions.aap.org\/selfserve\/ssPage.aspx?SelfServeContentId=Immunization_Schedules."},{"key":"bibr2-0024363918761715","author":"Armour Stephanie","year":"2015","journal-title":"Wall Street Journal"},{"key":"bibr3-0024363918761715","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-7-26"},{"key":"bibr4-0024363918761715","unstructured":"Catechism of the Catholic Church\n                      , 2nd ed. Revised in accordance with the official Latin text. Promulgated by Pope John Paul II."},{"key":"bibr5-0024363918761715","first-page":"279","volume":"54","author":"Centers for Disease Control and Prevention (CDC)","year":"2005","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"07","key":"bibr6-0024363918761715","first-page":"1","volume":"55","author":"Centers for Disease Control and Prevention (CDC)","year":"2006","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"bibr7-0024363918761715","unstructured":"Centers for Disease Control and Prevention (CDC). 2016. \u201cMeasles Cases and Outbreaks\u201d. http:\/\/www.cdc.gov\/measles\/cases-outbreaks.html."},{"key":"bibr8-0024363918761715","doi-asserted-by":"publisher","DOI":"10.1038\/nature.2016.19655"},{"key":"bibr9-0024363918761715","unstructured":"Congregation for the Doctrine of the Faith. 1987. Instruction on Respect for Human Life in Its Origin and on the Dignity of Procreation Replies to Certain Questions of the Day. http:\/\/www.vatican.va\/roman_curia\/congregations\/cfaith\/documents\/rc_con_cfaith_doc_19870222_respect-for-human-life_en.html."},{"key":"bibr10-0024363918761715","unstructured":"Congregation for the Doctrine of the Faith. 2008. Instruction Dignitas Personae: On Certain Bioethical Questions. http:\/\/www.vatican.va\/roman_curia\/congregations\/cfaith\/documents\/rc_con_cfaith_doc_20081208_dignitas-personae_en.html."},{"key":"bibr11-0024363918761715","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1601824"},{"key":"bibr12-0024363918761715","first-page":"359","volume":"343","author":"Gershon A.A.","year":"2010","journal-title":"Current Topics in Microbiology and Immunology"},{"key":"bibr13-0024363918761715","unstructured":"Glaxo Smith Kline. 2016. \u201cVaccines, HAVRIX, Pre-scribing Information\u201d. https:\/\/www.gsksource.com\/pharma\/content\/dam\/GlaxoSmithKline\/US\/en\/Prescribing_Information\/Havrix\/pdf\/HAVRIX.PDF."},{"key":"bibr14-0024363918761715","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2016.05.008"},{"key":"bibr15-0024363918761715","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510410040030"},{"key":"bibr16-0024363918761715","unstructured":"Merck. 2016a. \u201cVaccines, M-M-R-II, Prescribing Information\u201d. http:\/\/www.merck.com\/product\/usa\/pi_circulars\/m\/mmr_ii\/mmr_ii_pi.pdf."},{"key":"bibr17-0024363918761715","unstructured":"Merck. 2016b. \u201cVaccines, VARIVAX, Prescribing Information\u201d. http:\/\/www.merck.com\/product\/usa\/pi_circulars\/v\/varivax\/varivax_pi.pdf."},{"key":"bibr18-0024363918761715","unstructured":"Merck. 2016c. \u201cVaccines, ZOSTAVAX, Prescribing Information\u201d. http:\/\/www.merck.com\/product\/usa\/pi_circulars\/z\/zostavax\/zostavax_pi2.pdf."},{"key":"bibr19-0024363918761715","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1600651"},{"key":"bibr20-0024363918761715","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.1353"},{"key":"bibr21-0024363918761715","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1965.02090030401007"},{"key":"bibr22-0024363918761715","doi-asserted-by":"publisher","DOI":"10.5840\/ncbq20066334"},{"key":"bibr23-0024363918761715","doi-asserted-by":"publisher","DOI":"10.1086\/522145"},{"key":"bibr24-0024363918761715","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2008.12.002"},{"key":"bibr25-0024363918761715","volume-title":"Code of Federal Regulations Title 45 Public Welfare Department of Health and Human Services, Part 46 Protection of Human Subjects Subpart B: Additional Protections for Pregnant Women, Human Fetuses, and Neonates Involved in Research","author":"U.S. Department of Health and Human Services","year":"2009"},{"key":"bibr26-0024363918761715","doi-asserted-by":"publisher","DOI":"10.5840\/ncbq20066331"}],"container-title":["The Linacre Quarterly"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0024363918761715","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0024363918761715","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0024363918761715","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:14:52Z","timestamp":1777623292000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0024363918761715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.1177\/0024363918761715"],"URL":"https:\/\/doi.org\/10.1177\/0024363918761715","relation":{},"ISSN":["0024-3639","2050-8549"],"issn-type":[{"value":"0024-3639","type":"print"},{"value":"2050-8549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2]]}}}